Promising Candidate As An Anticancer Agent For Childhood, A Sesquiterpene Lactone: Dehydroleucodine

A Sesquiterpene Lactone: Dehydroleucodine

Authors

DOI:

https://doi.org/10.53555/bp.v7i12.1809

Abstract

Objective: Despite emerging new treatments, there is a need for new anti-cancer agents for childhood solid tumors. Sesquiterpene lactones(SLs) are plant-derived secondary metabolites with anti-cancer properties. Dehydroleucodine(DhL) is a guaianolide-type SL isolated from Artemisia douglasiana (Asteraceae). In this study, the cytotoxic, antiproliferative, apoptotic effects of DhL on childhood solid tumors including Ewing sarcoma(ES), Hepatoblastoma(HBL), and Neuroblastoma(NB) were investigated in in-vitro conditions.

Material and Methods: In this study, NB cell line KELLY, ES cell line SK-ES-1, and HBL cell line Hep-G2 were used. Cell lines were cultured and LD50 doses of DhL and Cisplatin(CDDP) were calculated by MTT. Effective doses were applied to all cell lines, and percentages of apoptosis and necrosis were determined by Annexin V-PI test in flow cytometry. Morphological changes in cells were examined by toluidine blue staining. Immunocytochemical(ICC) examinations were performed with Caspase3,8, and 9 to determine the mechanism of apoptosis as Ki67 proliferation index. Statistical analysis was performed using the Mann-Whitney U test at a statistical significance level of p<0,05.

Results:  LD50 doses of DhL and CDDP were determined as 75µM, 100µM for Kelly; 50µM, 100µM for HEP-G2; and 100µM, 300µM for SK-ES-1.

The intrinsic pathway in all cell lines was more pronounced in DhL, which reduced proliferation leading to apoptosis. DhL reduced proliferation less than CDDP and resulted in similar apoptotic cell death.

Conclusions: DhL showed a statistically significant anti-cancer activity similar to CDDP. It exerted this effect through apoptosis. Planning in-vivo experiments about this agent and explaining its molecular mechanisms, investigating the effects of other SL on childhood cancers are among our future goals.

Downloads

Download data is not yet available.

References

Bohlmann, F., Mahanta, P. K., Jakupovic, J., Rastogi, R. C. & Natu, A. A. New sesquiterpene lactones from Inula species. Phytochemistry (1978). doi:10.1016/S0031-9422(00)94308-5

Ren, Y., Yu, J. & Douglas Kinghorn, A. Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones. Curr. Med. Chem. 23, 2397–2420 (2016).

Chadwick, M., Trewin, H., Gawthrop, F. & Wagstaff, C. Sesquiterpenoids lactones: Benefits to plants and people. Int. J. Mol. Sci. 14, 12780–12805 (2013).

Ghantous, A., Gali-Muhtasib, H., Vuorela, H., Saliba, N. A. & Darwiche, N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov. Today 15, 668–678 (2010).

Zhang, Z. Y. et al. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: A randomized controlled trial. J. Chinese Integr. Med. (2008). doi:10.3736/jcim20080206

Berger, T. G. et al. Artesunate in the treatment of metastatic uveal melanoma - First experiences. Oncol. Rep. (2005). doi:10.3892/or.14.6.1599

Singh, N. P. & Verma, K. B. Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch. Oncol. (2002). doi:10.2298/AOO0204279S

Singh, N. P. & Panwar, V. K. Case report of a pituitary macroadenoma treated with artemether. Integr. Cancer Ther. (2006). doi:10.1177/1534735406295311

Zobalova, R. . et al. Drugs that kill cancer stem-like cells. Cancer Stem Cells Theor. Pract. 361–378 (2011). doi:10.5772/582

Tabata, K. et al. Sesquiterpene lactones derived from Saussurea lappa induce apoptosis and inhibit invasion and migration in neuroblastoma cells. J. Pharmacol. Sci. 127, 397–403 (2015).

Costantino, V. V. et al. Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis. Cancer Lett. 372, 10–23 (2016).

Ordóñez, P. E. et al. Dehydroleucodine, a Sesquiterpene Lactone from Gynoxys verrucosa, Demonstrates Cytotoxic Activity against Human Leukemia Cells. J. Nat. Prod. 79, 691–696 (2016).

Priestap, H. A. et al. Dehydroleucodine and dehydroparishin-B inhibit proliferation and motility of B16 melanoma cells. Phytochem. Lett. 5, 581–585 (2012).

Bailon-Moscoso, N. et al. Phytometabolite Dehydroleucodine induces cell cycle arrest, apoptosis, and DNA damage in human astrocytoma cells through p73/p53 regulation. PLoS One 10, 1–18 (2015).

Stacey, G. N. Cancer Cell Culture, MTT assay. Methods Mol Biol 731, 79–91 (2011).

Hingorani, R., Deng, J., Elia, J., McIntyre, C. & Mittar, D. Detection of Apoptosis Using the BD Annexin V FITC Assay on the BD FACSVerseTM System. BD Biosci. August, 1–12 (2011).

Antigen, S., Method, R., Steps, B., Protocol, I. S. & Xt, V. D. Ihc ventana protocol. 1, 1–2

Shaloam, D. & Tchounwou, P. B. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur. J. Pharmacol. (2014). doi:10.1016/j.ejphar.2014.07.025.Cisplatin

Gach, K., Długosz, A. & Janecka, A. The role of oxidative stress in anticancer activity of sesquiterpene lactones. Naunyn. Schmiedebergs. Arch. Pharmacol. (2015). doi:10.1007/s00210-015-1096-3

Rüngeler, P. et al. Inhibition of transcription factor NF-κB by sesquiterpene lactones: A proposed molecular mechanism of action. Bioorganic Med. Chem. 7, 2343–2352 (1999).

Facts, C. Cancer Facts & Figures 2020. American Cancer Society (2020).

Stewart, E. et al. The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Dev. Biol. 411, 287–293 (2016).

Ward, E. & DeSantis, C. Childhood and Adolescent Cancer Statistics, 2014. 64, 83–103 (2014).

Sharma.et.al. Primary Ewing’s Sarcoma of Cranium in a Pediatric Patient. J. Pediatr. Neurosci. 273–5 (2017). doi:10.4103/jpn.JPN

Olgun, N. & Çeçen, E. Nöroblastom. Kanser Gündemi 4, 120 (2016).

Tabata, K. et al. Sesquiterpene lactones derived from Saussurea lappa induce apoptosis and inhibit invasion and migration in neuroblastoma cells. J. Pharmacol. Sci. 127, 397–403 (2015).

Gach, K., Długosz, A. & Janecka, A. The role of oxidative stress in anticancer activity of sesquiterpene lactones. Naunyn. Schmiedebergs. Arch. Pharmacol. (2015). doi:10.1007/s00210-015-1096-3

Ordóñez, P. E. et al. Dehydroleucodine, a Sesquiterpene Lactone from Gynoxys verrucosa, Demonstrates Cytotoxic Activity against Human Leukemia Cells. J. Nat. Prod. 79, 691–696 (2016).

Priestap, H. A. et al. Dehydroleucodine and dehydroparishin-B inhibit proliferation and motility of B16 melanoma cells. Phytochem. Lett. 5, 581–585 (2012).

Bailon-Moscoso, N. et al. Phytometabolite Dehydroleucodine induces cell cycle arrest, apoptosis, and DNA damage in human astrocytoma cells through p73/p53 regulation. PLoS One 10, 1–18 (2015).

Downloads

Published

2021-12-31

How to Cite

Erol, A., Aktaş, S., & Gökbayrak, Özde. (2021). Promising Candidate As An Anticancer Agent For Childhood, A Sesquiterpene Lactone: Dehydroleucodine: A Sesquiterpene Lactone: Dehydroleucodine. International Journal For Research In Biology & Pharmacy, 7(12), 01–08. https://doi.org/10.53555/bp.v7i12.1809